{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:02:31Z","timestamp":1790719351088,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bprch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.beha.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T07:54:31Z","timestamp":1445241271000},"page":"253-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Hairy cell leukaemia-variant: Disease features and treatment"],"prefix":"10.1016","volume":"28","author":[{"given":"Estella","family":"Matutes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mart\u00ednez-Trillos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2015.09.002_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0145-2126(80)90066-1","article-title":"A\u00a0chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy-cell leukaemia","volume":"4","author":"Cawley","year":"1980","journal-title":"Leuk Res"},{"key":"10.1016\/j.beha.2015.09.002_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1096-8652(199610)53:2<121::AID-AJH11>3.0.CO;2-I","article-title":"Atypical prolymphocytic variant of hairy-cell leukemia: case report and review of the literature","volume":"53","author":"Dunphy","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2015.09.002_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2015.09.002_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V76.1.157.157","article-title":"A\u00a0variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients","volume":"76","author":"Sainati","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib5","unstructured":"Zinzani PL, Lauria F, Buzzi M, Raspadori D, Gugliotta L, Bocchia M, et\u00a0al. Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases. Haematologica;75:54\u20137."},{"key":"10.1016\/j.beha.2015.09.002_bib6","series-title":"WHO classification of tumours of haematopoieic and lymphoid tissue","first-page":"191","article-title":"Splenic B-cell lymphoma\/leukemia, unclassifiable","author":"Piris","year":"2008"},{"key":"10.1016\/j.beha.2015.09.002_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.leu.2401999","article-title":"The natural history and clinico-pathological features of the variant form of hairy cell leukemia","volume":"15","author":"Matutes","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2015.09.002_bib8","first-page":"181","article-title":"Predominance of a distinct subtype of hairy cell leukemia in Japan","volume":"7","author":"Machii","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2015.09.002_bib9","first-page":"303","article-title":"The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes","volume":"89","author":"Del Giudice","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2015.09.002_bib10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","author":"Pillai","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2015.09.002_bib11","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"Van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2015.09.002_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/leu.2011.47","article-title":"High-resolution genomic profiling in hairy cell leukemia-variant compared with typical hairy cell leukemia","volume":"25","author":"Hockley","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2015.09.002_bib13","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2009-03-212449","article-title":"Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior","volume":"114","author":"Forconi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2141.2009.07962.x","article-title":"Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns","volume":"148","author":"Hockley","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2015.09.002_bib15","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1182\/blood-2009-01-201731","article-title":"VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy","volume":"114","author":"Arons","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000523","article-title":"NOTCH1, TP53 and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease","author":"Martinez","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beha.2015.09.002_bib17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features","volume":"95","author":"Kanellis","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2015.09.002_bib18","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib19","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2011-09-379339","article-title":"Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation","volume":"119","author":"Xi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib20","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","article-title":"Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications","volume":"26","author":"Bikos","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2015.09.002_bib21","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","article-title":"Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features","volume":"72","author":"Navarro","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2015.09.002_bib22","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2015.09.002_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.2828","article-title":"High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias","volume":"46","author":"Waterfall","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2015.09.002_bib24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2015.09.002_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng.1045","article-title":"Spliceosome mutations in hematopoietic malignancies","volume":"44","author":"Hahn","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2015.09.002_bib27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.beha.2015.09.002_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1309\/AJCPUBHM8U7ZFLOB","article-title":"Aberrations of MYC are a common event in B-cell prolymphocytic leukemia","volume":"142","author":"Flatley","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2015.09.002_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2012.09163.x","article-title":"The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma","volume":"158","author":"Hockley","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2015.09.002_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2174\/156800912800673211","article-title":"Novel and emerging drugs for rarer chronic lymphoid leukaemias","volume":"12","author":"Matutes","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"issue":"Suppl. 5","key":"10.1016\/j.beha.2015.09.002_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/annonc\/mdv200","article-title":"Hairy cell leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","author":"Robak","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beha.2015.09.002_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ctrv.2006.04.010","article-title":"Current treatment options in hairy cell leukemia and hairy cell leukemia variant","volume":"32","author":"Robak","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.beha.2015.09.002_bib33","first-page":"1196","article-title":"Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress","volume":"46","author":"Makita","year":"2005","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.beha.2015.09.002_bib34","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/10428190500083433","article-title":"Successful treatment of hairy cell leukemia variant with rituximab","volume":"46","author":"Narat","year":"2005","journal-title":"Leuk Lymphoma"},{"issue":"Suppl. ECR26","key":"10.1016\/j.beha.2015.09.002_bib35","article-title":"Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab","volume":"90","author":"Quach","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2015.09.002_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00277-012-1612-1","article-title":"Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant","volume":"92","author":"Yoshida","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beha.2015.09.002_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.10428","article-title":"CD52 expression in hairy cell leukemia","volume":"74","author":"Quigley","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2015.09.002_bib38","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1556\/OH.2007.28169","article-title":"Successful alemtuzumab treatment of a patient with atypical hairy cell leukaemia variant","volume":"148","author":"Telek","year":"2007","journal-title":"Orv Hetil"},{"key":"10.1016\/j.beha.2015.09.002_bib39","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","article-title":"Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia","volume":"345","author":"Kreitman","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beha.2015.09.002_bib40","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1200\/JCO.2011.38.1756","article-title":"Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia","volume":"30","author":"Kreitman","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beha.2015.09.002_bib41","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2011-04-351502","article-title":"Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia","volume":"118","author":"Ravandi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.beha.2015.09.002_bib42","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.1158\/1078-0432.CCR-13-1752","article-title":"Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia","volume":"19","author":"Kreitman","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692615000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692615000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T23:33:40Z","timestamp":1599694420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692615000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1521692615000146"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2015.09.002","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hairy cell leukaemia-variant: Disease features and treatment","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}